Professor Claude Wischik
Chair in Mental Health (Clin)
- About
-
- Email Address
- c.m.wischik@abdn.ac.uk
- Office Address
TauRx Therapeutics Ltd
1st Floor, Sir Moir Lockhead Building
395 King Street
Aberdeen
AB24 5RP
United Kingdom
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Research
-
Research Overview
Molecular Neuropathology of Alzheimer's Disease, and in particular the therapeutic intervention of tau pathology
- Publications
-
Page 10 of 10 Results 91 to 96 of 96
Loss of synaptic, but not cytoskeletal proteins in the cerebellum of people with chronic schizophrenia
Schizophrenia Research, vol. 49, no. Suppl. 1, pp. 55Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/S0920-9964(01)00159-1
The molecular basis of tau protein pathology in Alzheimer's Disease and related neurodegenerative dementias
Neurobiology of Alzheimer’s Disease. Dawbarn, D., Allen, S. (eds.). 2 edition. Oxford University PressChapters in Books, Reports and Conference Proceedings: ChaptersStaging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease
American Journal of Pathology, vol. 157, no. 2, pp. 623-636Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0002-9440(10)64573-7
α-Synuclein inclusions in Alzheimer and Lewy body diseases
Journal of Neuropathology and Experimental Neurology, vol. 59, no. 5, pp. 408-417Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/jnen/59.5.408
- [ONLINE] View publication in Scopus
The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old
Acta Neuropathologica, vol. 100, pp. 29-35Contributions to Journals: Articlesalpha-synuclein inclusions in Alzheimer and Lewy body diseases
Journal of Neuropathology and Experimental Neurology, vol. 59, pp. 408-417Contributions to Journals: Articles